Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Certain gut bacteria may protect against hair loss, while others may increase the risk.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ritlecitinib is an effective new treatment for Alopecia Areata.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

New LSS gene variants help understand congenital hypotrichosis 14 better.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Dupilumab effectively treated severe alopecia areata in a child.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Wharton's jelly stem cells show diverse traits and functions.

DKK proteins could help diagnose and treat various non-cancerous diseases.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Stem cell therapy shows promise for treating skin disorders.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

CD44 signaling can help heal wounds without scars.

Unani treatment significantly regrows hair in young adults with androgenetic alopecia.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

GFC injections significantly improved hair growth and quality with minimal side effects.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

GFC is more effective than PRP for treating hair loss.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Laser hair removal effectiveness depends on targeting hair structures without harming the skin, and improvements require more research and expert collaboration.

Hoxc13 gene is essential for hair, nail, and papilla development.